Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. (2TZ)
XSTU
2.22
+0.02 (+0.91%)
Closed
Oct 7, 2026
Day's Range
2.202.22
52 wk Range
2.083.17
Financial Statements - 2TZ - Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
Revenue
4.91B▼ 32.7%
Net Income
2.11B▼ 4.7%Net Margin 42.9%
EBITDA
2.77B▼ 5.3%
Free Cash Flow
342.45M▼ 57.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.91B | 7.30B | 8.22B | 8.24B | 6.90B | 6.60B |
| Cost of Goods | 1.27B | 3.78B | 4.60B | 4.95B | 4.15B | 4.02B |
| Gross Profit | 3.63B | 3.52B | 3.61B | 3.29B | 2.75B | 2.57B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 971.15M | 855.21M | 868.25M | 723.34M | 613.17M | 595.93M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 2.48B | 2.57B | 1.09B | 980.18M | 872.80M | 768.05M |
| Income Tax | 376.70M | 363.56M | 126.65M | 106.93M | 85.92M | 88.39M |
| Net Income | 2.11B | 2.21B | 968.70M | 873.25M | 786.87M | 679.66M |
| EPS Basic | 2.77 | 2.9 | 1.28 | 1.12 | 1 | 0.86 |
| EPS Diluted | 2.77 | 2.89 | 1.28 | 1.11 | 1 | 0.86 |
| Basic Shares Outstanding | 769.32M | 768.73M | 6.06B | 5.81B | 5.81B | 5.81B |
| Diluted Shares Outstanding | 769.32M | 768.73M | 6.06B | 5.81B | 5.81B | 5.81B |
| Ebit | 2.49B | 2.61B | 1.13B | 990.45M | 875.74M | 768.06M |
| Ebitda | 2.77B | 2.92B | 1.35B | 1.16B | 996.89M | 876.80M |
| Net Income Continuous Operations | 2.11B | 2.21B | 968.70M | 873.25M | 786.87M | 679.66M |
| Minority Interests | 20.27M | 14.11M | 18M | -11.46M | -17.73M | -17.95M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
